Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Mombo Ngoma, Ghyslain ^a,b,c   Kleine, Christian ^a,b,d   Basra, Arti ^a,b   Würbel, Heike ^a,b   Diop, Daisy A ^a,b   Capan, Mesküre ^a,b,e   Adegnika, Ayola A ^a,b,f   Kurth, Florian ^a,b,g   Mordmüller, Benjamin ^a,b   Joanny, Fanny ^a,b   Kremsner, Peter G ^a,b   Ramharter, Michael ^a,b,e   Bélard, Sabine ^a,b,h  

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Artemether lumefantrine; Artemisinin combination therapy; Malaria; Malariae; Non falciparum; Ovale

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONVULSION; DIARRHEA; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GABON; HUMAN; LYMPHADENOPATHY; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MIXED INFECTION; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE MALARIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT RESPONSE; URINARY TRACT INFECTION; VOMITING; DRUG COMBINATION; DRUG TOXICITY; ISOLATION AND PURIFICATION; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; COINFECTION; DRUG COMBINATIONS; DRUG TOXICITY; ETHANOLAMINES; FEMALE; FLUORENES; GABON; HUMANS; MALARIA; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863665343     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-120     Document Type: Article

References (30)

1. Artemisinin-based combination therapy for treating uncomplicated malaria. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P, Cochrane Database Syst Rev 2009 3 D007483
2. Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis. Kurth F, Belard S, Adegnika AA, Gaye O, Kremsner PG, Ramharter M, Lancet Infect Dis 2010 10 125 132 10.1016/S1473-3099(09)70327-5 20113981
3. WHO, Guidelines for the treatment of malaria World Health Organization, Geneva Second 2010
4. Pubmed, Accessed on September 29th 2011. For 2001-2011
5. Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections. Borrmann S, Szlezak N, Binder RK, Missinou MA, Lell B, Kremsner PG, J Antimicrob Chemother 2002 50 751 754 10.1093/jac/dkf200 12407136 (Pubitemid 35331697)
6. High rate of mixed and subpatent malarial infections in southwest Nigeria. May J, Mockenhaupt FP, Ademowo OG, Falusi AG, Olumese PE, Bienzle U, Meyer CG, AmJTrop Med Hyg 1999 61 339 343 (Pubitemid 29380273)
7. Malaria in pregnant Cameroonian women: the effect of age and gravidity on submicroscopic and mixed-species infections and multiple parasite genotypes. Walker-Abbey A, Djokam RR, Eno A, Leke RF, Titanji VP, Fogako J, Sama G, Thuita LH, Beardslee E, Snounou G, Zhou A, Taylor DW, AmJTrop Med Hyg 2005 72 229 235 (Pubitemid 41278867)
8. WHO, http://www.who.int/malaria/diagnosis-treatment/finance/MoU- termination-report.pdf Access Date June 18th 2011.
9. History and perspectives of medical research at the Albert Schweitzer Hospital in Lambarene, Gabon. Ramharter M, Adegnika AA, Agnandji ST, Matsiegui PB, Grobusch MP, Winkler S, Graninger W, Krishna S, Yazdanbakhsh M, Mordmuller B, Lell B, Missinou MA, Mavoungou E, Issifou S, Kremsner PG, Wien Klin Wochenschr 2007 119 19-20 Suppl 3 8 12 17987353
10. Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. Sylla EH, Kun JF, Kremsner PG, Trans R Soc Trop Med Hyg 2000 94 652 656 10.1016/S0035-9203(00)90219-0 11198649
11. Adolescence as risk factor for adverse pregnancy outcome in Central Africa-a cross-sectional study. Kurth F, Belard S, Mombo-Ngoma G, Schuster K, Adegnika AA, Bouyou-Akotet MK, Kremsner PG, Ramharter M, PLoS One 2010 5 14367 10.1371/journal.pone.0014367 21188301
12. Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. Ramharter M, Schuster K, Bouyou-Akotet MK, Adegnika AA, Schmits K, Mombo-Ngoma G, Agnandji ST, Nemeth J, Afene SN, Issifou S, Onnas IN, Kombila M, Kremsner PG, AmJTrop Med Hyg 2007 77 418 422 (Pubitemid 351844312)
13. Epidemiology of parasitic co-infections during pregnancy in Lambarene, Gabon. Adegnika AA, Ramharter M, Agnandji ST, Ateba Ngoa U, Issifou S, Yazdanbahksh M, Kremsner PG, Trop Med Int Health 2010 15 1204 1209 10.1111/j.1365-3156.2010.02598.x 20636299
14. In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum. Ramharter M, Noedl H, Winkler H, Graninger W, Wernsdorfer WH, Kremsner PG, Winkler S, Antimicrob Agents Chemother 2003 47 3494 3499 10.1128/AAC.47.11.3494-3499.2003 14576107 (Pubitemid 37345709)
15. Polymorphisms in the parasite genes for pfcrt and pfmdr-1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambarene, Gabon. Binder RK, Borrmann S, Adegnika AA, Missinou MA, Kremsner PG, Kun JF, Parasitol Res 2002 88 475 476 10.1007/s00436-001-0546-7 12049468 (Pubitemid 34328098)
16. High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children. Mombo-Ngoma G, Oyakhirome S, Ord R, Gabor JJ, Greutelaers KC, Profanter K, Greutelaers B, Kurth F, Lell B, Kun JF, Issifou S, Roper C, Kremsner PG, Grobusch MP, Malar J 2011 10 123 10.1186/1475-2875-10-123 21569596
17. Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon. Ramharter M, Kurth FM, Belard S, Bouyou-Akotet MK, Mamfoumbi MM, Agnandji ST, Missinou MA, Adegnika AA, Issifou S, Cambon N, Heidecker JL, Kombila M, Kremsner PG, J Antimicrob Chemother 2007 60 1091 1096 10.1093/jac/dkm355 17884832 (Pubitemid 47617759)
18. Genetic polymorphisms influence Plasmodium ovale PCR detection accuracy. Calderaro A, Piccolo G, Perandin F, Gorrini C, Peruzzi S, Zuelli C, Ricci L, Manca N, Dettori G, Chezzi C, Snounou G, J Clin Microbiol 2007 45 1624 1627 10.1128/JCM.02316-06 17360843 (Pubitemid 46762425)
19. Comparison of PCR-based detection of Plasmodium falciparum infections based on single and multicopy genes. Oyedeji SI, Awobode HO, Monday GC, Kendjo E, Kremsner PG, Kun JF, Malar J 2007 6 112 10.1186/1475-2875-6-112 17705826 (Pubitemid 47397423)
20. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA, AmJTrop Med Hyg 1999 60 687 692 (Pubitemid 29233131)
21. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, Do Rosario VE, Thaithong S, Brown KN, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
22. Origin of the human malaria parasite Plasmodium falciparum in gorillas. Liu W, Li Y, Learn GH, Rudicell RS, Robertson JD, Keele BF, Ndjango JB, Sanz CM, Morgan DB, Locatelli S, Gonder MK, Kranzusch PJ, Walsh PD, Delaporte E, Mpoudi-Ngole E, Georgiev AV, Muller MN, Shaw GM, Peeters M, Sharp PM, Rayner JC, Hahn BH, Nature 2010 467 420 425 10.1038/nature09442 20864995
23. In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia. Siswantoro H, Russell B, Ratcliff A, Prasetyorini B, Chalfein F, Marfurt J, Kenangalem E, Wuwung M, Piera KA, Ebsworth EP, Anstey NM, Tjitra E, Price RN, Antimicrob Agents Chemother 2010 55 197 202 20937779
24. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria. Bassat Q, PLoS Negl Trop Dis 2011 5 1325 10.1371/journal.pntd.0001325 22216359
25. Artemisinin combination therapy for vivax malaria. Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN, Lancet Infect Dis 2010 10 405 416 10.1016/S1473-3099(10)70079-7 20510281
26. A comparison of three diagnostic techniques for malaria: a rapid diagnostic test (NOW Malaria), PCR and microscopy. Gatti S, Gramegna M, Bisoffi Z, Raglio A, Gulletta M, Klersy C, Bruno A, Maserati R, Madama S, Scaglia M, Ann Trop Med Parasitol 2007 101 195 204 10.1179/136485907X156997 17362594 (Pubitemid 47488149)
27. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum. Kreidenweiss A, Kremsner PG, Dietz K, Mordmuller B, AmJTrop Med Hyg 2006 75 1178 1181 (Pubitemid 351627504)
28. Plasmodium species co-infection as a cause of treatment failure. Smith A, Denholm J, Shortt J, Spelman D, Travel Med Infect Dis 2011 9 306 309 10.1016/j.tmaid.2011.09.006 22137441
29. Why doPlasmodium malariaeinfections sometimes occur in spite of previous antimalarial medication? Franken G, Muller-Stover I, Holtfreter MC, Walter S, Mehlhorn H, Labisch A, Haussinger D, Richter J, Parasitol Res 2012 Feb 18 Epub ahead of print.
30. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Pyae Phyo A, Valecha N, Rao BH, Tjitra E, Purnama A, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, PLoS One 2011 6 14501 10.1371/journal.pone.0014501 21267072